Author

R. Olayo-Alarcon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Dietl· 1 shared A. R. Brochado· 1 shared A. Ralser· 1 shared A. Zannoni· 1 shared C. L. Mueller· 1 shared C. L. Müller· 1 shared C. M. Sharma· 1 shared D. Singh· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Dietl

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pre-trained molecular representations enable antimicrobial discovery

R. Olayo-Alarcon, M. K. Amstalden, A. Zannoni, M. Bajramovic, C. M. Sharma, A. R. Brochado, M. Rezaei, C. L. Müller

This paper introduces a deep learning framework for antimicrobial discovery that identifies new compounds with antimicrobial potential using pre-trained molecular representations.

bioRxiv · Mar 11, 2024Microbiology

RNF43 is a gatekeeper for colitis-associated cancer

A. Dietl, A. Ralser, K. Taxauer, T. Dregelies, W. Sterlacci, M. Stadler, R. Olayo-Alarcon, S. Margaryan, M. Skerhut, T. Groll, K. Steiger, D. Singh, X. Li, R. Oellinger, R. Rad, , R. Mejias Luque

This study identifies RNF43 mutations as a driver of colitis-associated cancer by showing their role in promoting inflammation and dysbiosis in mouse models and human patients.

bioRxiv · Jan 30, 2024 · PreprintCancer Biology